The semisynthetic flavonoid monoHER sensitises human soft tissue sarcoma cells to doxorubicin-induced apoptosis via inhibition of nuclear factor-κB

BACKGROUND: Despite therapeutic advances, the prognosis of patients with metastatic soft tissue sarcoma (STS) remains extremely poor. The results of a recent clinical phase II study, evaluating the protective effects of the semisynthetic flavonoid 7-mono-O-(β-hydroxyethyl)-rutoside (monoHER) on doxo...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobs, H, Bast, A, Peters, G J, van der Vijgh, W J F, Haenen, G R M M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049564/
https://www.ncbi.nlm.nih.gov/pubmed/21245867
http://dx.doi.org/10.1038/sj.bjc.6606065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049564/
https://www.ncbi.nlm.nih.gov/pubmed/21245867
http://dx.doi.org/10.1038/sj.bjc.6606065

Ejemplares similares